There is a real case for a Japanese company to list on Nasdaq, and there is a real cost. A data site should state both, because the pipeline shows issuers are still choosing the route — ten tracked names are on file and pending — while the completed cohort shows a −70% median return.
The pitch, stated fairly
Nasdaq offers a Japanese issuer three things the domestic market often does not: access to a deep US retail and institutional capital base, global visibility and a US-dollar valuation, and — for a deep-tech or growth story — a comparables set that can price innovation more richly than the Tokyo market. For a company whose customers, investors or ambitions are international, a US listing is a legitimate strategic choice, not vanity.
The pitch is not false. It is just incomplete without the base rate — and the base rate is the thing the pitch never includes.
The base rate, stated plainly
Of the seventeen tracked names that listed and trade, one is above its IPO price (PCLA, +18.3%) and the median is −70.3%. TOYO (−34.7%) is among the *better* survivors. Any issuer weighing the pitch above should weigh it against that distribution, not against the single success story a banker will lead with.
Who is still choosing it, and why it can still be right
The pipeline is not empty. KOEI (Koei Group, recycling), SEAH (Seahawk, recycling), ADBT (Advasa, earned-wage-access software) and others are on file. For some of them the route will be correct — a genuine US customer base, a technology that prices better abroad, a strategic reason the Tokyo market cannot serve. The decision is not 'Nasdaq yes/no.' It is: does this specific company have the operating substance and the raise discipline that separated the one name that worked from the sixteen that did not?
That is the honest frame. Nasdaq is a real option with a real, unflattering base rate. The site's job is to give a prospective issuer both numbers before a banker gives them only one.